Skip to content

MiniMed Group

US · MMED #2009 by market cap Listed 2026
16.01 -0.25 -1.54%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:47

Price chart

Pre-market 16.12 -0.86%
After-hours 16.21 +1.25%
23.8410.8016.012026-05-262026-11-20
MA5MA10MA20MA60
— MA5 — MA10 — MA20 — MA60
Reader sentiment Are you bullish or bearish on MMED?

Anonymous reader poll. Unscientific, not investment advice.

✦ StockVane Quant Insights how this is computed

Quant Sentiment Neutral
  • Recent price momentum is -20.7% on average (3-month/1-year).
  • Main-fund capital flow has been a net inflow over the last 45 sessions.
  • Short interest has risen to 3.5% of float.
  • Analyst tilt is Buy.
Quant Technical Outlook Bearish
  • Price is below its 20-day average and below its 60-day average.
  • The 20-day average is below the 60-day average, a short-term downtrend.
Quant Rating, last 30 days C → C

Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.

Factor grades

Ranked against 2848 U.S. stocks StockVane covers.

Last computed: 2026-11-22 08:27 UTC

Data coverage: 5 of 6 factors. Missing data is not a zero score.

Overall C+

The radar needs all six factors. Available grades are shown below.

Valuation C

How expensive the stock is versus earnings, sales and its own 5-year history.

Forward P/E 36.6x Better than 12%
Price / Sales 1.6x Better than 65%
Growth N/A

How fast revenue, profit and free cash flow are compounding.

Not enough data to grade this factor.

Profitability C-

How much profit the business keeps from each dollar of sales and capital.

Gross margin 54.2% Better than 68%
Operating margin -5.1% Better than 17%
Net margin -10.7% Better than 15%
Return on equity -9.6% Better than 20%
Return on invested capital -9.4% Better than 18%
Momentum B-

Recent price strength, skipping the latest month to avoid short-term noise.

3-month return -21.7% Better than 28%
6-month return 34.9% Better than 91%
Distance below 52-week high 34.5% Better than 35%
Financial Health A-

Balance-sheet strength: leverage, liquidity and interest coverage.

Current ratio 1.9x Better than 54%
Debt to assets 3.1% Better than 84%
Analyst View A-

What the Street thinks: share of Buy ratings and upside to the average target.

Analysts rating Buy 84.6% Better than 66%
Upside to average target 65.0% Better than 74%

Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector. Background recomputation is scheduled every 6 hours; actual computation time is shown above, and source datasets have different reporting dates. Not investment advice or tailored to your financial situation.

Performance

1W -11.01%
1M -8.46%
3M -20.66%
6M +37.66%

Key statistics

Price & volume

Prev close
16.26
Open
16.08
Day range
15.92 - 16.79
Avg price
16.15
Volume
4.58M
Turnover
73.94M
Amplitude
5.35%
52-week range
10.65 - 24.43

Valuation

P/E
-12.32
P/E (TTM)
-14.21
P/B
1.24
EPS
-1.30
Net profit
-365.75M
Net assets
3.62B

Share structure

Market cap
4.50B
Float cap
455.75M
Shares out
281.35M
Float shares
28.47M

Dividend & listing

Dividend (TTM)
0.00
Listing date
2026-03-06
52-week range 39% of range
10.65 24.43

34.5% below the 52-week high

Trading activity

Net capital flow main funds, last 45 sessions

+69.52M net over the window

Short interest

Shares short
9.81M
As of
2026-10-30

Frequently asked questions

What is the current stock price of MiniMed Group (MMED)?

MiniMed Group last traded at 16.01. This page shows a periodic quote snapshot. Check the displayed quote time.

What is MiniMed Group's market cap?

About 4.50B.

What is the P/E ratio of MiniMed Group?

The trailing twelve-month P/E is -14.21. The Valuation tab shows it against the stock's own five-year range.

Does MiniMed Group pay a dividend?

MiniMed Group does not currently pay a regular dividend.

Is MiniMed Group a buy according to analysts?

The consensus of 13 analysts is a Buy rating, with an average 12-month price target of 26.42, which implies 65.0% upside from the current price. This is not investment advice.

What is MiniMed Group's StockVane Quant Rating?

The StockVane Momentum strategy currently rates MiniMed Group a C (Hold). Mid-pack momentum — held if you own it, not a fresh buy. Not investment advice.

Quote time 2026-11-20 19:47:52 · For reference only, not investment advice and not tailored to your situation.

MiniMed Group discussion 0 comments

Add a comment